Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunhawk Vision BiotechROCO:7759 +0.33%20 Current Ratio is 13.57 as of Jun. 2026, which is 53% below its 10-year median of 28.68. GuruFocus rates ROCO:7759 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 1,409 Biotechnology companies, Sunhawk Vision Biotech ranks better than 85.31% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sunhawk Vision Biotech's current ratio for the quarter that ended in Jun. 2026 was 13.57.
Sunhawk Vision Biotech has a current ratio of 13.57. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Sunhawk Vision Biotech's Current Ratio or its related term are showing as below:
ROCO:7759'
s Current Ratio Range Over the Past 10 Years
Min: 13.57 Med: 28.68 Max: 7646.7
Current: 13.57
During the past 6 years, Sunhawk Vision Biotech's highest Current Ratio was 7646.70. The lowest was 13.57. And the median was 28.68.
ROCO:7759's Current Ratio is ranked better than 85.31% of 1409
companies
in the Biotechnology industry
Industry Median: 3.89
vs ROCO:7759: 13.57
Sunhawk Vision Biotech (ROCO:7759) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sunhawk Vision Biotech Current Ratio Related Terms
Sunhawk Vision Biotech Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7759 vs VRTX, REGN, MRNA: Current Ratio Comparison
For the Biotechnology subindustry, Sunhawk Vision Biotech's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunhawk Vision Biotech Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunhawk Vision Biotech's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sunhawk Vision Biotech's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunhawk Vision Biotech (ROCO:7759) has a Current Ratio of 13.57 as of Jun. 2026. This is 53% below median its historical median of 28.68. Over the past decade, Sunhawk Vision Biotech's Current Ratio has ranged from 13.57 to 7,646.70. According to the industry distribution chart, Sunhawk Vision Biotech ranks #207 out of 1409 companies in the Biotechnology industry, placing it in the top 14.7%.
Is Sunhawk Vision Biotech's Current Ratio too high?
Sunhawk Vision Biotech's current Current Ratio of 13.57 is 53% below median its 10-year median of 28.68. Over the past 10 years, this metric has ranged from a low of 13.57 to a high of 7,646.70. The Biotechnology industry median Current Ratio is 3.89. Sunhawk Vision Biotech's value of 13.57 is 248.8% above this industry median. Based on the distribution chart, Sunhawk Vision Biotech ranks #207 out of 1409 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sunhawk Vision Biotech has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunhawk Vision Biotech ranks #207 out of 1409 companies for Current Ratio. This places Sunhawk Vision Biotech in the top 15% of its industry — outperforming the majority of peers. The industry median Current Ratio is 3.89. Sunhawk Vision Biotech's value of 13.57 is 248.8% above this benchmark. Historically, Sunhawk Vision Biotech's own Current Ratio has ranged from 13.57 to 7,646.70 over the past decade. While the company's 10-year median is 28.68 vs. the industry median of 3.89, Sunhawk Vision Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunhawk Vision Biotech's current Current Ratio of 13.57 is 248.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunhawk Vision Biotech's current Current Ratio is 13.57, which is 53% below median its own 10-year median of 28.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current Current Ratio of 13.57. The current Current Ratio is 13.57, which is 53% below median its 10-year median of 28.68 and 248.8% above the Biotechnology industry median of 3.89. Sunhawk Vision Biotech's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current Current Ratio is 13.57 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
20GF Score
Get the complete analysis for ROCO:7759
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7759 has been successfully added to your 
